Dr. Satadal Das discusses a unique study exploring Bryonia alba as an emerging alternative therapeutic agent for liver cancer. The research, published in Case Reports in Clinical Radiology, investigates the impact of ultra-diluted ethanol extracts on HepG2 liver cancer cells. Dr. Das shares insights into the rationale behind the study, its significance for future integrative cancer care, and his positive experience collaborating with the Scientific Scholar editorial team. The study highlights the growing intersection of traditional remedies and modern clinical science. Case Reports in Clinical Radiology is published by Scientific Scholar.
This news was covered by Medical Dialogues.